Ondansetron HCl Orally Disintegrating Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to compare the relative bioavailability of the test
formulation of Ondansetron HCl with the already marketed reference formulation Zofran ODT
under fasting conditions in healthy, non-smoking adult subjects.